A Study to Learn if TBE Vaccine was Safe in Healthy Japanese People 1 Year of Age and Older, and if TBE Vaccine Produced an Immune Response Against a Germ called Tick-Borne Encephalitis Virus. A Phase 3, Single-Arm, Open-Label Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis Vaccine in Healthy Japanese Participants 1 Year of Age and Older.